Beijing Winland Medical Co., Ltd.

WinLand Medical is a global medical technology company specializing in the development and manufacture of high-precision diagnostic and monitoring devices based on infrared spectroscopy. Established in 1996 and headquartered in Beijing, the company focuses on respiratory gas analysis and in-vitro diagnostics (IVD), offering key products such as the 13C-Urea Breath Test for Helicobacter pylori detection and fractional exhaled nitric oxide (FeNO) analyzers for asthma management. The company also provides a comprehensive suite of capnography solutions, including mainstream and sidestream EtCO2 sensors and multi-gas monitors for anesthesia and intensive care applications. WinLand Medical operates a global distribution network and maintains an international office in the United States to support its expanding footprint in the respiratory and diagnostic sectors.